Abstract Metabolic remodelling underlies tumour progression. However, how metabolites act as signalling molecules to support cancer cell proliferation remains unclear. Here we show that argininosuccinate (ASA), a key intermediate of the urea cycle, promotes purine nucleoside biosynthesis in tyrosine kinase-driven haematological malignancies. Mechanistically, BCR–ABL phosphorylates argininosuccinate synthase 1 (ASS1), which increases ASA production from citrulline.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xiaojing
Contact Xiaojing, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack